227 related articles for article (PubMed ID: 16467949)
1. [Gaucher disease, Fabry disease and mucopolysaccharidosis type I--how can the rheumatologist recognise these patients?].
Manger B; Menge E; Schaefer R; Haase C; Seidel J; Michels H
Z Rheumatol; 2006 Feb; 65(1):32, 34-43. PubMed ID: 16467949
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologic aspects of lysosomal storage diseases.
Manger B; Mengel E; Schaefer RM
Clin Rheumatol; 2007 Mar; 26(3):335-41. PubMed ID: 16680390
[TBL] [Abstract][Full Text] [Related]
3. Treatable lysosomal storage diseases in the advent of disease-specific therapy.
Peters H; Ellaway C; Nicholls K; Reardon K; Szer J
Intern Med J; 2020 Nov; 50 Suppl 4():5-27. PubMed ID: 33210402
[TBL] [Abstract][Full Text] [Related]
4. Gaucher and Fabry diseases: from understanding pathophysiology to rational therapies.
Brady RO
Acta Paediatr Suppl; 2003 Dec; 92(443):19-24. PubMed ID: 14989461
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses.
Ferraz MJ; Kallemeijn WW; Mirzaian M; Herrera Moro D; Marques A; Wisse P; Boot RG; Willems LI; Overkleeft HS; Aerts JM
Biochim Biophys Acta; 2014 May; 1841(5):811-25. PubMed ID: 24239767
[TBL] [Abstract][Full Text] [Related]
6. Patients' view on gene therapy development for lysosomal storage disorders: a qualitative study.
Eskes ECB; Beishuizen CRL; Corazolla EM; van Middelaar T; Brands MMMG; Dekker H; van de Mheen E; Langeveld M; Hollak CEM; Sjouke B
Orphanet J Rare Dis; 2022 Oct; 17(1):383. PubMed ID: 36271424
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
[TBL] [Abstract][Full Text] [Related]
8. [How does the landscape change in lysosomal storage disease].
Parini R
Pediatr Med Chir; 2007; 29(5):275-8. PubMed ID: 18402399
[No Abstract] [Full Text] [Related]
9. Diagnostic challenges and new therapies for rare lysosomal storage diseases.
Hesselgrave B
Case Manager; 2003; 14(6):48-52. PubMed ID: 14618149
[No Abstract] [Full Text] [Related]
10. What should rheumatologists know about Gaucher disease and Fabry disease? Connecting the dots for an overview.
Cordeiro RA; Rosa Neto NS; Giardini HAM
Adv Rheumatol; 2024 Mar; 64(1):22. PubMed ID: 38520029
[TBL] [Abstract][Full Text] [Related]
11. [Lysosomal storage diseases].
Manger B
Z Rheumatol; 2010 Aug; 69(6):527-38. PubMed ID: 20532791
[TBL] [Abstract][Full Text] [Related]
12. Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).
Pastores GM; Meere PA
Curr Opin Rheumatol; 2005 Jan; 17(1):70-8. PubMed ID: 15604908
[TBL] [Abstract][Full Text] [Related]
13. The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey.
Mengel E; Gaedeke J; Gothe H; Krupka S; Lachmann A; Reinke J; Ohlmeier C
PLoS One; 2020; 15(12):e0244279. PubMed ID: 33382737
[TBL] [Abstract][Full Text] [Related]
14. Home therapy for lysosomal storage disorders.
Hughes DA; Mlilligan A; Mehta A
Br J Nurs; 2007 Dec 13-2008 Jan 9; 16(22):1384, 1386-9. PubMed ID: 18361386
[TBL] [Abstract][Full Text] [Related]
15. Simplified newborn screening protocol for lysosomal storage disorders.
Metz TF; Mechtler TP; Orsini JJ; Martin M; Shushan B; Herman JL; Ratschmann R; Item CB; Streubel B; Herkner KR; Kasper DC
Clin Chem; 2011 Sep; 57(9):1286-94. PubMed ID: 21771947
[TBL] [Abstract][Full Text] [Related]
16. The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry disease.
Hollak CE; Weinreb NJ
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):205-18. PubMed ID: 25987174
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal storage disorders. Diagnosis by ultrastructural examination of skin biopsy specimens.
O'Brien JS; Bernett J; Veath ML; Paa D
Arch Neurol; 1975 Sep; 32(9):592-9. PubMed ID: 809024
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
19. Treating lysosomal storage disorders: What have we learnt?
Lachmann RH
J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Gaucher Disease in India - Consensus Guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics.
Puri RD; Kapoor S; Kishnani PS; Dalal A; Gupta N; Muranjan M; Phadke SR; Sachdeva A; Verma IC; Mistry PK;
Indian Pediatr; 2018 Feb; 55(2):143-153. PubMed ID: 29503270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
